OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
9.19
-0.29 (-3.01%)
Nov 10, 2026, 2:07 PM EST - Market open
OptimizeRx Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 173 | 229 | 90 | 260 | 288 | 1,104 | |
Market Cap Growth | -40.69% | 155.27% | -65.54% | -9.86% | -73.89% | 134.43% |
Enterprise Value | 168 | 238 | 109 | 196 | 210 | 1,019 |
Last Close Price | 9.47 | 12.26 | 4.86 | 14.31 | 16.80 | 62.11 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.32 | 44.53 | - | - | - | 2919.14 |
Forward PE | 10.29 | 17.36 | 18.07 | 47.18 | 39.84 | 106.12 |
PS Ratio | 1.74 | 2.09 | 0.97 | 3.63 | 4.61 | 18.01 |
PB Ratio | 1.36 | 1.78 | 0.77 | 2.05 | 2.29 | 8.40 |
P/TBV Ratio | 7.98 | 13.74 | 146.04 | - | 3.19 | 10.41 |
P/FCF Ratio | 9.34 | 12.25 | 18.74 | - | 27.26 | 1763.84 |
P/OCF Ratio | 9.30 | 12.21 | 18.31 | - | 27.05 | 1520.12 |
PEG Ratio | - | 2.94 | 2.94 | 2.94 | 2.66 | 2.12 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.69 | 2.17 | 1.18 | 2.75 | 3.36 | 16.63 |
EV/EBITDA Ratio | 10.73 | 14.50 | - | - | - | 438.00 |
EV/EBIT Ratio | 14.82 | 19.70 | - | - | - | 2821.85 |
EV/FCF Ratio | 9.09 | 12.74 | 22.84 | - | 19.83 | 1628.49 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.15 | 0.20 | 0.28 | 0.29 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 1.23 | 1.57 | - | - | - | 0.13 |
Debt / FCF Ratio | 1.06 | 1.40 | 6.95 | - | 0.02 | 0.52 |
Net Debt / Equity Ratio | -0.04 | 0.02 | 0.17 | 0.18 | -0.59 | -0.64 |
Net Debt / EBITDA Ratio | -0.30 | 0.17 | -12.04 | -2.12 | 7.20 | -36.26 |
Net Debt / FCF Ratio | -0.25 | 0.15 | 4.15 | -3.13 | -6.99 | -134.81 |
Asset Turnover | 0.59 | 0.63 | 0.52 | 0.45 | 0.45 | 0.61 |
Quick Ratio | 5.27 | 2.91 | 2.77 | 2.86 | 11.47 | 11.69 |
Current Ratio | 5.58 | 3.04 | 2.89 | 3.04 | 11.74 | 12.29 |
Return on Equity (ROE) | 3.67% | 4.18% | -16.51% | -13.91% | -8.88% | 0.42% |
Return on Assets (ROA) | 4.22% | 4.33% | -2.11% | -5.21% | -5.57% | 0.22% |
Return on Invested Capital (ROIC) | 5.91% | 6.65% | -4.17% | -13.14% | -24.77% | 0.83% |
Return on Capital Employed (ROCE) | 7.30% | 7.70% | -3.90% | -8.00% | -9.70% | 0.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.68% | 2.25% | -22.46% | -6.76% | -3.97% | 0.03% |
FCF Yield | 10.70% | 8.16% | 5.34% | -2.82% | 3.67% | 0.06% |
Buyback Yield / Dilution | -3.84% | -3.86% | -6.82% | 3.71% | -0.53% | -19.30% |